Phase I and pharmacokinetic study of irinotecan administered as a low-dose, continuous intravenous infusion over 14 days in patients with malignant solid tumors

V.M.M. Herben, J.H.M. Schellens, J.H. Beijnen, W.W. ten Bokkel Huinink

Research output: Contribution to journalArticleProfessional

Original languageUndefined/Unknown
Pages (from-to)1897-1905
Number of pages8
JournalJournal of Clinical Oncology
Volume17
Publication statusPublished - 1999

Cite this